[1]张迎春.间苯三酚与米索前列醇对宫腔镜术前宫颈扩张效果及不良反应的影响[J].医学信息,2024,37(15):87-90.[doi:10.3969/j.issn.1006-1959.2024.15.019]
　ZHANG Ying-chun.Effect of Phloroglucinol and Misoprostol on Cervical Dilatation and Adverse Reactions Before Hysteroscopy[J].Journal of Medical Information,2024,37(15):87-90.[doi:10.3969/j.issn.1006-1959.2024.15.019]
点击复制

间苯三酚与米索前列醇对宫腔镜术前宫颈扩张效果及不良反应的影响()

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
37卷
期数:
2024年15期
页码:
87-90
栏目:
论著
出版日期:
2024-08-01

文章信息/Info

Title:
Effect of Phloroglucinol and Misoprostol on Cervical Dilatation and Adverse Reactions Before Hysteroscopy
文章编号:
1006-1959（2024）15-0087-04
作者:
张迎春
（湖口县人民医院妇产科，江西 湖口 332500）
Author(s):
ZHANG Ying-chun
(Department of Obstetrics and Gynecology,Hukou County People’s Hospital,Hukou 332500,Jiangxi,China)
关键词:
宫腔镜手术; 宫颈扩张; 间苯三酚; 米索前列醇
Keywords:
Hysteroscopic surgery; Cervical dilatation; Phloroglucinol; Misoprostol
分类号:
R713
DOI:
10.3969/j.issn.1006-1959.2024.15.019
文献标志码:
A
摘要:
目的 研究间苯三酚与米索前列醇对宫腔镜术前宫颈扩张效果及不良反应的影响。方法 以2020年1月-2023年3月湖口县人民医院拟行宫腔镜术治疗的60例患者为研究对象，经随机数字表法分为间苯三酚组与米索前列醇组，各30例。间苯三酚组采用间苯三酚进行术前预处理，米索前列醇组则采用米索前列醇完成术前预处理，比较两组术前宫颈扩张效果、扩张宫颈时间、术中出血量、宫颈撕裂发生率、术中并发症及不良反应发生情况。结果 两组术前宫颈扩张效果比较，差异无统计学意义（P＞0.05）；间苯三酚组扩张宫颈时间短于米索前列醇组（P＜0.05），但两组术中出血量、宫颈撕裂发生率比较，差异无统计学意义（P＞0.05）；间苯三酚组术中并发症发生率低于米索前列醇组（P＜0.05）；间苯三酚组不良反应发生率低于米索前列醇组（P＜0.05）。结论 间苯三酚与米索前列醇均为宫腔镜术前预处理药物，二者宫颈扩张效果相当，但间苯三酚扩张宫颈时间更短、术中并发症及不良反应风险更低。
Abstract:
Objective To study the effect of phloroglucinol and misoprostol on cervical dilatation and adverse reactions before hysteroscopy.Methods From January 2020 to March 2023, 60 patients undergoing hysteroscopic surgery in Hukou County People’s Hospital were selected as the research objects. They were divided into phloroglucinol group and misoprostol group by random number table method, with 30 patients in each group. The phloroglucinol group was treated with phloroglucinol for preoperative pretreatment, and the misoprostol group was treated with misoprostol for preoperative pretreatment. The preoperative cervical dilatation effect, cervical dilatation time, intraoperative blood loss, incidence of cervical tear, intraoperative complications and adverse reactions were compared between the two groups.Results There was no significant difference in the effect of preoperative cervical dilatation between the two groups (P>0.05). The time of cervical dilatation in phloroglucinol group was shorter than that in misoprostol group (P<0.05). The incidence of intraoperative complications in the phloroglucinol group was lower than that in the misoprostol group (P<0.05). The incidence of adverse reactions in the phloroglucinol group was lower than that in the misoprostol group (P<0.05).Conclusion Phloroglucinol and misoprostol are both pretreatment drugs before hysteroscopic surgery, the effect of cervical dilatation is similar, but phloroglucinol has shorter cervical dilatation time and lower risk of intraoperative complications and adverse reactions.

参考文献/References:

[1]Xu L,Wang C,Dai S,et al.Intravenous lidocaine attenuates response to cervical dilation for hysteroscopy: a randomised controlled trial[J].British Journal of Anaesthesia,2021,27(5):e166-e168.[2]宋文榕,潘琳,孙莉.不同剂量米索前列醇对宫腔镜下异常子宫出血妇女宫颈进入的影响[J].山西医药杂志,2022,51(15):1745-1748.[3]申平,高燕.宫腔粘连患者宫腔镜术前三种宫颈预处理方式的临床疗效分析[J].贵州医药,2022,46(4):566-567.[4]刘松君,陈琳琳,石吟,等.不同宫颈软化方法应用于绝经后患者宫腔镜手术前宫颈扩张的效果比较[J].浙江医学,2022,44(7):733-736,741.[5]刘颖蔚,邓幼林,曹毅.日间病房宫腔镜手术前宫颈管扩张方法研究[J].中国性科学,2021,30(1):99-101.[6]Xie Y,Lu J,Yang T,et al.Phloroglucinol, a clinical-used antispasmodic, inhibits amyloid aggregation and degrades the pre-formed amyloid proteins[J].Int J Biol Macromol,2022,213:675-689.[7]Bridi H,Meirelles GC,von Poser GL.Structural diversity and biological activities of phloroglucinol derivatives from Hypericum species[J].Phytochemistry,2018,155:203-232.[8]郭彩霞,李志红.米索前列醇用于足月促宫颈成熟289例疗效评价[J].中国药物与临床,2020,20(17):2868-2869.[9]Abdelhakim AM,Gadallah AH,Abbas AM.Efficacy and safety of oral vs vaginal misoprostol for cervical priming before hysteroscopy: A systematic review and meta-analysis - Science Direct[J].Eur J Obstet Gynecol Reprod Biol,2019,243:111-119.[10]苑家林,佟玲玲,蔡立夫,等.米索前列醇联合洛索洛芬在绝经妇女宫腔镜检查中的应用[J].中国实验诊断学,2019,23(3):506-507.[11]Sun J,Shi C,Liang Y,et al.Effects of early second-look hysteroscopy combined with intrauterine balloon dilatation on reproductive outcomes for women with intrauterine adhesions[J].Int J Gynaecol Obstet,2020,149(2):192-196.[12]Casadei L,Piccolo E,Manicuti C,et al.Role of vaginal estradiol pretreatment combined with vaginal misoprostol for cervical ripening before operative hysteroscopy in postmenopausal women[J].Obstet Gynecol Sci,2016,59(3):220-226.[13]于曼,黄健荣,梁碧秀,等.阴道放置卡孕栓与米索前列醇对宫腔镜子宫黏膜下肌瘤电切术扩张宫颈效果[J].中国计划生育学杂志,2018,26(12):1189-1191.[14]Ganer Herman H,Kerner R,Gluck O,et al.Different routes of misoprostol for same-day cervical priming prior to hysteroscopy: a randomized controlled single-blinded trial[J].J Minim Invasive Gynecol,2017,24(3):455-460.[15]Mathuriya G,Verma N,Pandey S.A comparative study of efficacy and safety of intramuscular carboprost and intravaginal misoprostol for cervical priming prior to first trimester surgical abortion[J].Medip Academy,2019,1(11):514-520.[16]程树花,胡文伟.序贯应用米非司酮及米索前列醇终止瘢痕子宫早期妊娠的临床观察[J].中国药物与临床,2021,21(16):2848-2850.[17]杨帆,郑雪绒,杨鉴冰,等.米索前列醇联合马来酸麦角新碱治疗产后出血90例分析[J].临床药物治疗杂志,2020,18(1):69-73.[18]罗才全,左国会.术前应用间苯三酚联合奥布卡因对宫腔镜手术患者宫颈软化程度、VRS评分及不良反应的影响[J].医学临床研究,2019,36(10):1926-1928.[19]付凤仙,段华,汪沙,等.间苯三酚在绝经期患者宫腔镜手术中的应用[J].中国微创外科杂志,2019,19(2):137-140.[20]邵翠芳,夏丽萍.复方萘普生栓联合间苯三酚在绝经后妇女无创宫腔镜检查中的应用[J].贵州医药,2019,43(10):1594-1595.[21]吴迪,祝俊,杨杨,等.间苯三酚或戊酸雌二醇联合米索前列醇用于绝经2年以上妇女取器的临床效果[J].中国计划生育学杂志,2023,31(1):117-120.[22]王铁军,张晔,张岩.米非司酮、米索前列醇预处理联合宫腔镜手术对于Ⅱ型剖宫产瘢痕妊娠的疗效分析[J].中国现代应用药学,2021,38(1):87-90.[23]李晓燕,郭琳雯,王陶然,等.绝经后异常子宫出血患者宫腔镜术前三种宫颈预处理方法的临床比较[J].北京医学,2019,41(3):198-201.[24]任伟,李立丽,史慧星,等.复方萘普生栓联合间苯三酚在绝经期出血妇女行宫腔镜检查中的应用[J].中国医药导报,2018,15(21):78-81.[25]Clara B,Paul V,Denis P,et al.Efficacy of phloroglucinol for the treatment of pain of gynaecologic or obstetrical origin: a systematic review of literature of randomised controlled trials[J].Eur J Clin Pharmacol,2020,76(1):1-6.

更新日期/Last Update: 1900-01-01